2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Clinical genetics<br />
P01.257<br />
s248F mutation in cHNRA4 gene has a pathogenic role in<br />
autosomal dominant nocturnal frontal lobe epilepsy<br />
A. Zuniga, E. Pineda, I. Pitarch, A. Guerrero;<br />
Hospital de la Ribera, Alzira (Valencia), Spain.<br />
Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE, OMIM<br />
600513) has long been misdiagnosed as nocturnal paroxysmal dystonia,<br />
parasomnias, or psychiatric disturbances . It is characterized by<br />
clusters <strong>of</strong> brief nocturnal motor seizures, which originate in the frontal<br />
cortex . The results <strong>of</strong> interictal electroencephalogram are usually normal,<br />
as are computed tomographic scans and magnetic resonance images<br />
. Seizures are usually well controlled by carbamazepine; however,<br />
the recurrence risk after drug withdrawal <strong>of</strong>ten persists for life . This<br />
syndrome is inherited as an autosomal dominant disorder with a penetrance<br />
<strong>of</strong> 70% to 80% . Mutations in the alfa-4 subunit <strong>of</strong> the neuronal<br />
nicotinic acetylcholine receptor gene (CHRNA4) has been described in<br />
several families as responsible <strong>of</strong> ADNFLE .<br />
We have studied a family with ADNFLE from the east <strong>of</strong> Spain . The<br />
clinical appearance <strong>of</strong> the disease in this family was very similar to previously<br />
described cases in which mutations in exon 5 <strong>of</strong> the CHRNA4<br />
gene were found . So, the exon 5 <strong>of</strong> the CHRNA4 gene was amplified<br />
between nucleotides 535 and 825 and polymerase chain reaction<br />
products were purified and sequenced directly. We have identified in<br />
three affected members <strong>of</strong> family a identify a C-to-T transition in the<br />
CHRNA4 gene, resulting in a Ser-248-to-Phe (S248F) substitution in<br />
the sixth amino acid position <strong>of</strong> the transmembrane domain 2 (M2) .<br />
Some authors have suggested that the mutation caused reduced receptor<br />
function . These data support the hypothesis that the phenotypic<br />
expression <strong>of</strong> autosomal dominant nocturnal frontal lobe epilepsy is<br />
caused by mutations in the CHRNA4 gene .<br />
P01.258<br />
Further delineation <strong>of</strong> the partial trisomy 3q phenotype<br />
D. Mueller1 , W. Mueller2 , F. Fresser1 , G. Utermann1 , D. Kotzot1 ;<br />
1 2 Division for Clinical <strong>Genetics</strong>, Innsbruck, Austria, Department <strong>of</strong> Pediatrics,<br />
Reutte, Austria.<br />
Partial trisomy 3q is characterized by postnatal growth retardation, microcephaly,<br />
developmental delay, and distinct facial dysmorphisms .<br />
Here, we report on a 3 years and 7 months old girl with minor dysmorphic<br />
features (high frontal hairline, down-slanting palpebral fissures,<br />
telecanthus, epicanthus, bulbous nasal tip, long philtrum, tapering<br />
fingers, and short 5th fingers) and language accentuated development<br />
delay due to partial trisomy 3q and partial monosomy 4p born to<br />
healthy parents (mother 20 years, father 33 years) . After an unremarkable<br />
pregnancy, she was spontaneously delivered at term . Weight was<br />
3920g (>90th percentile), length was 51cm (50-75th percentile), and<br />
OFC was 36 .5cm (>90th percentile) . At the age <strong>of</strong> 39 months height<br />
was 100cm (50-75th percentile), weight was 17 .3kg (90-97th percentile),<br />
and OFC was 52cm (97th percentile) .<br />
GTG-banding and FISH with subtelomeric probes (Total Telomer Probe<br />
Panel, Vysis ® ) and a probe specific for the Wolf-Hirschhorn syndrome<br />
critical region (WHSCR) were performed according to standard procedures<br />
and revealed a de novo trisomy 3q27->qtel and monosomy<br />
4p16->ptel with a breackpoint distal to the WHSCR and proximal to<br />
the subtelomeric 4p probe (karyotype: 46,XX,der(4)t(3;4)(q27;p16) .ish<br />
der(4)(t(3;4)(D3S4560+;D4S3359-,WHSC1+CEP4+)) . For a more exact<br />
breakpoint determination SNP-array analysis is underway .<br />
In accordance with the cytogenetic results the girl shows no clinical<br />
features <strong>of</strong> WHS, but facial dysmorphisms clearly resembling partial<br />
trisomy 3q . The lack <strong>of</strong> postnatal growth retardation, microcephaly, and<br />
malformations in our patient will help to improve genotype-phenotype<br />
correlation in partial trisomy 3q .<br />
P01.259<br />
Optimizing clinical diagnosis for some genetic syndromes with<br />
cleft lip and/or palate (Iasi Medical <strong>Genetics</strong> Center’s experience)<br />
E. Braha, M. Volosciuc, C. Rusu, M. Covic;<br />
University <strong>of</strong> Medicine and Pharmacy, Iasi, Romania.<br />
Clefts <strong>of</strong> the lip (CL) and/or palate (CP) are among the most common<br />
birth defects and require multidisciplinary approach for diagnosis and<br />
treatment . The purpose <strong>of</strong> this report is to optimizing the clinical diagnosis<br />
<strong>of</strong> some genetic syndromes for the patients with CL/P . We selected<br />
106 patients (58 boys and 48 girls) with CL/P from the 8615 total<br />
patients evaluated in Iasi Medical <strong>Genetics</strong> Centre in 2000-2004 . The<br />
most patients (47 .2%) had CLP (19 .8% bilateral) or a CP (47 .2%); only<br />
5 .66% had CL . We look at other anomalies associated with CL/P, associations<br />
which have a high power to suggest the diagnosis . We used<br />
diagnosis algorithms and POSSUM, OMD databases .The 52 .83% (56<br />
patients) had CL/P associated with syndromes that include anomalies<br />
involving multiple organs . Only 47 .17% were non-syndromic . Base on<br />
evocative signs the syndromes diagnosed in our selected cohort were:<br />
oculo-auriculo-vertebral spectrum (6), velocardi<strong>of</strong>acial syndrome (6),<br />
chromosomal anomalies (5), amniotic bands (3), Smith Lemli Opitz (3),<br />
EEC (3), holoprozencephaly (2), fetal alcohool (2), Aarskog (2), other<br />
rare syndromes (18) . For accurate assessment, correct diagnosis, and<br />
management, the patients should be dealt with in a team approach .<br />
CL/P are frequent associated with others anomalies which emphasize<br />
the importance <strong>of</strong> plurimalformative syndromes identification. Clinical<br />
proper diagnosis is essential to initiate genetic test, the correct management<br />
and genetic counselling .<br />
P01.260<br />
Bannayan-Riley-Ruvalcaba syndrome confirmed by mutation in<br />
PTEN gene<br />
R. Zordania, A. Lehtmets, H. Põder, K. Joost;<br />
Tallinn` Children`s Hospital, Tallinn, Estonia.<br />
Bannayan-Riley-Ruvalcaba (BRRS) and Cowden (CS) syndromes are<br />
autosomal dominant allelic multiple hamartoma syndromes, both in<br />
60-80% cases due to germline mutations in tumor supressor PTEN<br />
gene . Clinical signs in childhood have many similarities, early diagnosis<br />
using molecular genetic analysis is important as syndromes give<br />
increased risk for different tumors .<br />
We describe a family, where both young parents <strong>of</strong> our index patient<br />
were treated due to tumors- mother had bladder carcinoma, treated<br />
during pregnancy and father was treated due to embryonal testicular<br />
carcinoma .<br />
Proband is the first and only child in the family. His birth anthropometry<br />
(4020g/52cm, OFC 41cm) was above 97th centile. During the first<br />
two years <strong>of</strong> his life he had psychomotor developmental problems,<br />
hypotonia, seizures with EEG changes, autistic features, unilateral hydrocele<br />
and macrocephaly . Metabolic workshop excluded metabolic<br />
disorders .<br />
At the age <strong>of</strong> three years three lipomas were (histologically<br />
proved)diagnosed- two subcutaneous and one pancreatic . The patient<br />
had different skin symptoms, no pigmentation <strong>of</strong> the glans penis . He<br />
had macrocephaly and mild mental retardation and some autistic features<br />
and speech problems .<br />
Mutation analysis <strong>of</strong> PTEN gene was performed by Dr .D .O .Robinsin<br />
(Salisbury Health Care NHS Trust) . The patient is carring a C>A substitution<br />
at base 144, in exon 2 <strong>of</strong> the PTEN gene . This mutation impairs<br />
the function <strong>of</strong> PTEN and is the cause <strong>of</strong> the patient`s symptoms .<br />
conclusion: clinical, pedigree data and results <strong>of</strong> moleculargenetic<br />
investigations <strong>of</strong> the patient having Bannayan-Riley-Ruvalcaba syndrome<br />
are presented. This is the first case <strong>of</strong> this syndrome in Estonia<br />
confirmed PTEN gene mutation .<br />
P01.261<br />
Report <strong>of</strong> cockayne syndrome from iranian families<br />
F. Afroozan, N. Almadani, Y. Shafeghati, M. H. Kariminejad;<br />
Kariminejad-Najmabadi Pathology and <strong>Genetics</strong> Center, Tehran, Islamic Republic<br />
<strong>of</strong> Iran.<br />
Cocakyne Syndrome is an autosomal recessive multisystemic<br />
condition,characterized by usually senile-like changes beginning ininfancy<br />
.<br />
Retinal degeneration,Impaired hearing and photosensitivity <strong>of</strong> thinskin<br />
.<br />
The disease is known to be genetically heterogeneous for which 3different<br />
Loci have been identified on chromosomes 10,12,13.We have<br />
studied five Iranian families,each with one affected child(threemale,two<br />
female) .three <strong>of</strong> these cases are results <strong>of</strong> cansanguineous marrige<br />
and the parents <strong>of</strong> the two cases are <strong>of</strong>fspring <strong>of</strong> unrelated<br />
couples .Their features and radiology were compatible with Cockayne<br />
Syndrome .<br />
The opthalmologist showed salt&pepper retinal pigmentation for two<br />
<strong>of</strong>the affected children and optic atrophy for other three cases .<br />
Assayes <strong>of</strong> DNA repair are performed on skin fibroblasts.The most-